Patents by Inventor Yiliang Zhang

Yiliang Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240094406
    Abstract: The present invention provides a GPS interference source positioning method, apparatus, electronic device, and readable storage medium, which relates to the technical field of wireless communications.
    Type: Application
    Filed: June 13, 2023
    Publication date: March 21, 2024
    Inventors: Zhiyong FENG, Sai HUANG, Jingchun LI, Yiliang CHEN, Ping ZHANG, Shuo CHANG
  • Publication number: 20240083994
    Abstract: Provided are a cell strain for producing a biosimilar drug of Ustekinumab and a production method therefor. Specifically, provided is a Chinese hamster ovary cell S cell strain. The cell strain expresses a full human monoclonal antibody directed against the P40 subunit shared by human IL-12 and human IL-23. The fully human monoclonal antibody directed against the P40 subunit shared by human IL-12 and human IL-23 is a biosimilar drug of Ustekinumab, which not only exhibits high consistency with Ustekinumab in pre-clinical research, but also passes pharmacokinetic bioequivalence and safety similarity evaluation in clinical research. The biosimilar drug of Ustekinumab is the first one that has entered clinical trials in China, is the only one that has completed the I stage clinical trial, and is also one of the biosimilar drugs of Ustekinumab, which has the fastest progress in new drug application in the world.
    Type: Application
    Filed: March 23, 2021
    Publication date: March 14, 2024
    Applicant: QYUNS THERAPEUTICS CO., LTD.
    Inventors: Zhengxue XU, Tao LI, Yin CHEN, Wenjun HUANG, Yi WANG, Huaiyao QIAO, Min FANG, Yiliang WU, Mengdan ZHANG
  • Patent number: 11928089
    Abstract: A data processing method includes: after receiving an export request for exporting data from the distributed database, acquiring, by a database import and export management node an active transaction list and export table distribution information at a current moment; notifying, by the database import and export management node, a corresponding database that the corresponding database performs a data export operation according to the export table distribution information; after determining that the corresponding database completes the data export operation, sending, by the database import and export management node, the active transaction list to a database agent node of the corresponding database; and after receiving a data consistency reverse compensation statement returned by the database agent node, importing, by the database import and export management node, the data exported by the corresponding database into a predetermined database and instructing the predetermined database to execute the data consist
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: March 12, 2024
    Assignee: ZTE CORPORATION
    Inventors: Longbo Guo, Yan Ding, Yiliang Xu, Peng Zhang, Jiashun Lu
  • Publication number: 20170342054
    Abstract: Indole compounds are disclosed. Also disclosed are methods for using the compounds to treat human and animal disease, pharmaceutical compositions of the compounds, and kits including the compounds.
    Type: Application
    Filed: January 5, 2017
    Publication date: November 30, 2017
    Inventors: Amy Elder, Geraldine Harriman, Silvana Leit, Jie Li, Howard P. Sard, Yiliang Zhang, Douglas Wilson
  • Publication number: 20150284365
    Abstract: Indole compounds are disclosed. Also disclosed are methods for using the compounds to treat human and animal disease, pharmaceutical compositions of the compounds, and kits including the compounds.
    Type: Application
    Filed: November 4, 2014
    Publication date: October 8, 2015
    Applicant: GALENEA CORPORATION
    Inventors: Amy Elder, Geraldine Harriman, Silvana Leit, Jie Li, Howard P. Sard, Yiliang Zhang, Douglas Wilson
  • Patent number: 8912220
    Abstract: Indole compounds are disclosed. Also disclosed are methods for using the compounds to treat human and animal disease, pharmaceutical compositions of the compounds, and kits including the compounds.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: December 16, 2014
    Inventors: Amy Elder, Geraldine Harriman, Silvana Leit, Jie Li, Howard Sard, Yiliang Zhang, Doug Wilson
  • Publication number: 20110144090
    Abstract: Indole compounds are disclosed. Also disclosed are methods for using the compounds to treat human and animal disease, pharmaceutical compositions of the compounds, and kits including the compounds.
    Type: Application
    Filed: August 10, 2010
    Publication date: June 16, 2011
    Inventors: Amy Elder, Geraldine Harriman, Silvana Leit, Jie Li, Howard Sard, Yiliang Zhang, Doug Wilson
  • Publication number: 20090318527
    Abstract: Novel indole compounds are disclosed. Also disclosed are methods for using the compounds to treat human and animal disease, pharmaceutical compositions of the compounds, and kits including the compounds.
    Type: Application
    Filed: February 11, 2009
    Publication date: December 24, 2009
    Inventors: Howard Sard, Yiliang Zhang, Jie Li, Louis Shuster, Bryan Roth, Niels Jensen
  • Patent number: D889436
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: July 7, 2020
    Inventor: Yiliang Zhang